Lyra Therapeutics
LYRA
LYRA
60 hedge funds and large institutions have $222M invested in Lyra Therapeutics in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 21 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
78% more capital invested
Capital invested by funds: $125M → $222M (+$97.1M)
36% more funds holding
Funds holding: 44 → 60 (+16)
0.32% more ownership
Funds ownership: 1.29% → 1.61% (+0.32%)
Holders
60
Holding in Top 10
2
Calls
$1.27M
Puts
$27K
Top Buyers
| 1 | +$15.7M | |
| 2 | +$8.65M | |
| 3 | +$3.14M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.09M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$680K |
Top Sellers
| 1 | -$2.42M | |
| 2 | -$2.32M | |
| 3 | -$512K | |
| 4 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$117K |
| 5 |
VF
Virtu Financial
New York
|
-$77K |